Developer docs
API playgroundTry for free, no card

Search company profiles

Aescuvest

Full company profile

uuid0002h15

Namestring
Aescuvest
Legal namestring
Aescuvest GmbH
Websiteurl
aescuvest.eu
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersFrankfurt, Germany
HQ citystring
Frankfurt
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthtech venture capital, deal-by-deal investing, special purpose vehicles, healthcare investment platform, SPV fund management
Industry2 codes
PRIMARYFSAAAMAK
Unit Registry & Transfer Agency for Alternatives (Private Funds, SPVs, Closed-End)
Financial & Insurance/Asset & Wealth Management/Asset Management — Fund Administration & Transfer Agency
SECONDARYFSAAAGAG
Insurance General Accounts (Institutional Asset Owners)
Financial & Insurance/Asset & Wealth Management/Asset Management — Institutional (Pensions, Endowments, Sovereign)
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Other Financial Vehicles52599
SIC code2 codes
  • Investment Advice6282
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Healthtech Venture Capital
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeSubscription Recurring
Description

Management fee charged on committed SPV capital. Fees are disclosed per deal in SPV documentation before any commitment.

aescuvest.vc
2Carried Interest
TypeLicensing Royalties
Description

Carried interest on profits from successful exits. Aescuvest co-invests in every round.

aescuvest.vc
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Aescuvest operates as a European deal-by-deal healthtech venture capital firm that sources, structures, and co-invests in individual healthtech rounds alongside business angels, family offices, and corporate partners. Each financing round is executed through a dedicated Special Purpose Vehicle (SPV), enabling qualified investors to review and commit to opportunities individually with full disclosure. The firm applies proprietary AI-assisted diligence (Acelia) and operates an investor portal plus a founder application platform (aescuvest.app) to manage deal flow, subscription, and reporting.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Healthtech exit horizons run several years for early-stage rounds and shorter for later-stage approvals-track investments.
Product overview1 text field

Aescuvest operates as a deal-by-deal healthtech venture capital firm offering multiple interconnected products: its core SPV Investment Platform enables qualified investors to participate in individual healthtech funding rounds, while the Acelia AI diligence copilot accelerates due diligence evaluation. The aescuvest.app platform provides a gateway for healthtech founders to apply for funding with AI-assisted intake and scoring, and the Investor Portal on bunch.capital handles subscription management, legal documentation, and investor reporting across all SPVs.

Product and service4 records
1Aescuvest SPV Investment Platform
CategoryVenture Capital Services
Description

A core venture capital platform that structures dedicated SPVs for each individual healthtech financing round, enabling qualified investors to participate in deals they select with full disclosure of terms, diligence packs, and term sheets before commitment.

2Acelia AI Diligence Copilot
CategoryInvestment Technology
Description

AI-powered diligence tool used during the due diligence process to accelerate evaluation of clinical, IP, regulatory, and financial information on potential portfolio companies.

3aescuvest.app Founder Application Platform
CategoryDeal-flow Platform
Description

AI-assisted deal-flow platform for healthtech founders to submit funding applications, featuring structured questionnaires, automated intake and scoring, and first-round diligence. Founders apply through the platform.

4Investor Portal (bunch.capital)
CategoryInvestor Reporting Platform
Description

Investor access portal hosted on bunch.capital for managing subscriptions, accessing legal documents, and viewing reporting for each SPV investment individually.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1European and Middle Eastern Networks
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership networks across Europe and the Middle East that surface healthtech founders before broader networks see them. Provides first-look access to clinically validated, regulatory-aware teams.

aescuvest.vc
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

OurCrowd is an Israel-based deal-by-deal venture investing platform with strong healthtech and deep-tech deal flow, allowing investors to subscribe to individual SPVs. Highly comparable to Aescuvest given shared geographic exposure (Israel/Middle East) and healthcare investment focus.

TypeDirect peer
Description

Seedrs is a European private-investing platform that structures nominee/SPV wrappers for individual deals so investors can participate deal-by-deal. Comparable to Aescuvest in operating a regulated, deal-level SPV subscription model across Europe, though across sectors rather than healthtech-only.

TypeDirect peer
Description

btov Partners is a European venture firm with a dedicated Digital Health and Industrial Tech franchise, investing across DACH and beyond. Comparable to Aescuvest as a European healthtech-focused VC serving a similar investor community.

TypeRegional player
Description

HV Capital is a German-headquartered European VC with a Health practice. Comparable as a DACH-rooted VC with healthtech exposure, though it operates a traditional fund structure rather than Aescuvest's SPV-by-deal approach.

TypeDirect peer
Description

Heal Capital is a European healthtech-focused venture fund backed by major insurers and corporates. Comparable to Aescuvest in its exclusive focus on digital health investing across Europe and emphasis on healthcare-industry LPs.

TypeBroad incumbent
Description

Speedinvest operates a dedicated Health fund alongside broader consumer/tech funds, backing European digital health startups. Comparable as a European healthtech-active investor, but offers a much broader sector portfolio than Aescuvest's exclusive healthtech focus.

TypeDirect peer
Description

Crowdcube runs per-deal SPV-style structures for European private investments, enabling retail and qualified investors to subscribe to individual rounds. Comparable to Aescuvest in offering deal-by-deal transparency and SPV-based subscription mechanics in Europe.

TypeDirect peer
Description

Earlybird's Health fund invests in European healthtech and digital health companies. Comparable to Aescuvest in targeting the same sub-vertical themes (digital diagnostics, personalised medicine) across DACH and broader Europe.

TypeBroad incumbent
Description

Wellington Partners is a long-established European technology and healthcare VC firm with a dedicated life sciences practice. Comparable as a healthtech-active European VC but operating as a traditional blind-pool fund manager rather than deal-by-deal SPV platform.

TypeDirect peer
Description

AngelList pioneered rolling-fund and SPV-by-deal structures for venture investing, allowing investors to back individual startups through dedicated vehicles. It is the closest direct competitor to Aescuvest's deal-by-deal SPV model, with a similar emphasis on investor transparency and per-deal subscription.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment25 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aescuvest

Healthtech Venture Capitalaescuvest.eu

Aescuvest firmographics

Firmographics
Name
Aescuvest
Legal name
Aescuvest GmbH
Website
https://aescuvest.eu
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Aescuvest industry classification

Industry
Product category
Healthtech Venture Capital
NAICS
Portfolio Management and Investment Advice (523940), Other Financial Vehicles (52599)
SIC
Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)
akta.pro industry
PRIMARYFSAAAMAK
Unit Registry & Transfer Agency for Alternatives (Private Funds, SPVs, Closed-End)
Financial & Insurance/Asset & Wealth Management/Asset Management — Fund Administration & Transfer Agency
SECONDARYFSAAAGAG
Insurance General Accounts (Institutional Asset Owners)
Financial & Insurance/Asset & Wealth Management/Asset Management — Institutional (Pensions, Endowments, Sovereign)

Keywords

  • Healthtech venture capital
  • Deal-by-deal investing
  • Special purpose vehicles
  • Healthcare investment platform
  • SPV fund management

Where Aescuvest is headquartered

Location

Headquarters

HQ city
Frankfurt
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Aescuvest business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Management Fees: Management fee charged on committed SPV capital. Fees are disclosed per deal in SPV documentation before any commitment.
  2. Carried Interest: Carried interest on profits from successful exits. Aescuvest co-invests in every round.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Aescuvest product offering

Product offering

Core offering

Aescuvest operates as a European deal-by-deal healthtech venture capital firm that sources, structures, and co-invests in individual healthtech rounds alongside business angels, family offices, and corporate partners. Each financing round is executed through a dedicated Special Purpose Vehicle (SPV), enabling qualified investors to review and commit to opportunities individually with full disclosure. The firm applies proprietary AI-assisted diligence (Acelia) and operates an investor portal plus a founder application platform (aescuvest.app) to manage deal flow, subscription, and reporting.

Product overview

Aescuvest operates as a deal-by-deal healthtech venture capital firm offering multiple interconnected products: its core SPV Investment Platform enables qualified investors to participate in individual healthtech funding rounds, while the Acelia AI diligence copilot accelerates due diligence evaluation. The aescuvest.app platform provides a gateway for healthtech founders to apply for funding with AI-assisted intake and scoring, and the Investor Portal on bunch.capital handles subscription management, legal documentation, and investor reporting across all SPVs.

Differentiator

Problem solved

Functional benefit

Products and services

  • Aescuvest SPV Investment Platform A core venture capital platform that structures dedicated SPVs for each individual healthtech financing round, enabling qualified investors to participate in deals they select with full disclosure of terms, diligence packs, and term sheets before commitment.
  • Acelia AI Diligence Copilot AI-powered diligence tool used during the due diligence process to accelerate evaluation of clinical, IP, regulatory, and financial information on potential portfolio companies.
  • aescuvest.app Founder Application Platform AI-assisted deal-flow platform for healthtech founders to submit funding applications, featuring structured questionnaires, automated intake and scoring, and first-round diligence. Founders apply through the platform.
  • Investor Portal (bunch.capital) Investor access portal hosted on bunch.capital for managing subscriptions, accessing legal documents, and viewing reporting for each SPV investment individually.

Quantifiable outcome

  • Healthtech exit horizons run several years for early-stage rounds and shorter for later-stage approvals-track investments.

Companies that use Aescuvest

Customer profile

Segments4 records

Ideal customer profiles5 records

Aescuvest technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Aescuvest partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • European and Middle Eastern NetworkscoreStrategic or Co-development PartnerPartnership networks across Europe and the Middle East that surface healthtech founders before broader networks see them. Provides first-look access to clinically validated, regulatory-aware teams.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Aescuvest competitors and assessment

Company assessment

Direct peers

  • OurCrowd: OurCrowd is an Israel-based deal-by-deal venture investing platform with strong healthtech and deep-tech deal flow, allowing investors to subscribe to individual SPVs. Highly comparable to Aescuvest given shared geographic exposure (Israel/Middle East) and healthcare investment focus.
  • Seedrs: Seedrs is a European private-investing platform that structures nominee/SPV wrappers for individual deals so investors can participate deal-by-deal. Comparable to Aescuvest in operating a regulated, deal-level SPV subscription model across Europe, though across sectors rather than healthtech-only.
  • btov Partners: btov Partners is a European venture firm with a dedicated Digital Health and Industrial Tech franchise, investing across DACH and beyond. Comparable to Aescuvest as a European healthtech-focused VC serving a similar investor community.
  • Heal Capital: Heal Capital is a European healthtech-focused venture fund backed by major insurers and corporates. Comparable to Aescuvest in its exclusive focus on digital health investing across Europe and emphasis on healthcare-industry LPs.
  • Crowdcube: Crowdcube runs per-deal SPV-style structures for European private investments, enabling retail and qualified investors to subscribe to individual rounds. Comparable to Aescuvest in offering deal-by-deal transparency and SPV-based subscription mechanics in Europe.
  • Earlybird Health: Earlybird's Health fund invests in European healthtech and digital health companies. Comparable to Aescuvest in targeting the same sub-vertical themes (digital diagnostics, personalised medicine) across DACH and broader Europe.
  • AngelList (Ally): AngelList pioneered rolling-fund and SPV-by-deal structures for venture investing, allowing investors to back individual startups through dedicated vehicles. It is the closest direct competitor to Aescuvest's deal-by-deal SPV model, with a similar emphasis on investor transparency and per-deal subscription.

Regional players

  • HV Capital: HV Capital is a German-headquartered European VC with a Health practice. Comparable as a DACH-rooted VC with healthtech exposure, though it operates a traditional fund structure rather than Aescuvest's SPV-by-deal approach.

Broad incumbents

  • Speedinvest Health: Speedinvest operates a dedicated Health fund alongside broader consumer/tech funds, backing European digital health startups. Comparable as a European healthtech-active investor, but offers a much broader sector portfolio than Aescuvest's exclusive healthtech focus.
  • Wellington Partners: Wellington Partners is a long-established European technology and healthcare VC firm with a dedicated life sciences practice. Comparable as a healthtech-active European VC but operating as a traditional blind-pool fund manager rather than deal-by-deal SPV platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Aescuvest social profiles

Digital presence

Aescuvest financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aescuvest leadership team

Management profile

Number of profiles

Profiles5 records

Aescuvest funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aescuvest M&A and investment

M&A and investment

M&A

Investments25 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aescuvest

What does Aescuvest do?

Aescuvest operates as a European deal-by-deal healthtech venture capital firm that sources, structures, and co-invests in individual healthtech rounds alongside business angels, family offices, and corporate partners. Each financing round is executed through a dedicated Special Purpose Vehicle (SPV), enabling qualified investors to review and commit to opportunities individually with full disclosure. The firm applies proprietary AI-assisted diligence (Acelia) and operates an investor portal plus a founder application platform (aescuvest.app) to manage deal flow, subscription, and reporting.

Is Aescuvest a public or private company?

Aescuvest is a private company. It is classified as venture growth investor backed and is currently operating.

When was Aescuvest founded?

Aescuvest was founded in 2014. It employs 1 to 10 people.

Where is Aescuvest based?

Aescuvest is headquartered in Frankfurt, Germany, in the Europe region.

How does Aescuvest make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.

Who are Aescuvest's main competitors?

Direct peers on record are OurCrowd, Seedrs, btov Partners, Heal Capital, Crowdcube, Earlybird Health and AngelList (Ally). HV Capital is listed as a regional player. Broad incumbents are Speedinvest Health and Wellington Partners.

Does Aescuvest have an API?

No public API is recorded for Aescuvest.

What industry is Aescuvest in?

Aescuvest's product category is Healthtech Venture Capital. Its primary akta.pro industry code is FSAAAMAK, Unit Registry & Transfer Agency for Alternatives (Private Funds, SPVs, Closed-End), with a secondary code of FSAAAGAG, Insurance General Accounts (Institutional Asset Owners). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooAescuvest Capital Partners (ACP) Fund Empowers Visionary Healthtech Innovators for High ReturnsAescuvest Capital Partners (ACP) is a healthcare investment firm targeting ventures near MDR and FDA approvals, with a patient-centred strategy. Its portfolio includes diagnostics and caregiving tech, and it dedicates 5% of earnings to Nurse Heroes. ACP will present at DxPx Europe in Munich on Jan 26-27.PR NewswireAescuvest Capital Partners (ACP) Fund Empowers Visionary Healthtech Innovators for High ReturnsAescuvest Capital Partners (ACP) is a healthtech investment firm targeting companies near MDR and FDA approvals, with a patient-centred strategy. Its portfolio includes diagnostics and caregiving solutions, and it dedicates 5% of earnings to Nurse Heroes. ACP will present at the DxPx Europe Conference in Munich on Jan 26-27, 2025.Pulse 2.0Neteera: Contactless Patient Monitoring Market Raises $6.7 MillionNeteera Technologies raised about $6.7 million in a Series B extension led by Aescuvest and Foxconn Technology. The funding will accelerate production and deployment of its FDA-cleared contactless patient monitoring platform, with manufacturing cooperation underway.PR NewswireNeteera raises an additional $6.7M Series B ExtensionNeteera Technologies Ltd. announced the closing of a $6.7 million Series B extension round led by Aescuvest with participation from Foxconn Technology Co., Ltd. The funds will be used to expedite production and deployment of its contactless patient monitoring platform, supported by a new manufacturing partnership with Foxconn. This development follows the company's recent expansion into selling solutions to long-term care facilities in the US.NeteeraNeteera Raises an Additional $6.7M Series B ExtensionNeteera Technologies Ltd. closed a $6.7 million Series B extension led by Aescuvest and Foxconn Technology Co., Ltd. (FTC). The funding will be used to expedite production, meet increasing demand, and recruit deployment personnel for its contactless patient monitoring platform. This partnership with Foxconn aims to boost international growth and mass production capabilities.Medical BuyerNeteera raises an additional $6.7M Series B extensionNeteera Technologies Ltd. closed a $6.7 million Series B extension round led by Aescuvest with participation from Foxconn Technology Co., Ltd. The raised capital will be used to accelerate production, meet growing demand, and recruit deployment personnel for its contactless patient monitoring platform. This funding supports a manufacturing partnership with Foxconn to facilitate mass production and international expansion.YahooNeteera Secures ~$13M Series B Funding for Contactless Patient MonitoringNeteera Technologies closed a ~$13M Series B funding round led by Aescuvest, with Omega Healthcare Investors joining as a strategic partner. The company will use the funds to accelerate sales and deployment of its contactless patient monitoring platform. Neteera plans to expand its reach and further develop its medical sensing platform.PR NewswireNeteera Secures ~$13M Series B Funding for Contactless Patient MonitoringNeteera Technologies closed a ~$13M Series B funding round led by Aescuvest, with Omega Healthcare Investors joining as a strategic partner. The company will use the funds to accelerate sales, production, and deployment of its contactless patient monitoring platform. Neteera plans to expand its reach and further develop its medical sensing platform.PR NewswireNeteera Secures ~$13M Series B Funding for Contactless Patient MonitoringNeteera Technologies announced the closing of a $13 million Series B funding round led by Aescuvest, with participation from Omega Healthcare Investors and other firms. Alongside this investment, Neteera entered into a strategic partnership with Omega Healthcare Investors to deploy its contactless patient monitoring technology across Omega's network of long-term care facilities in the United States.CrowdFund InsiderInvestment Crowdfunding Platform aescuvest Goes Pan European for Healthcare SectorAescuvest, a German crowdfunding platform, will operate pan-European for healthcare SMEs, partnering with EIT Health. The first financing campaign is planned for Q4 2018, targeting biotech, medical tech, and digital health. The platform will allow investments up to €10 million with a prospectus.